Deborah Forst

Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells

Philipp Karschnia, Justin T. Jordan, Deborah Forst et al. · Blood · 2019 · 329 citations · Full text

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.

A Rahman, Joseph Treat, Jae Kyung Roh et al. · Journal of Clinical Oncology · 1990 · 161 citations

Cumulative Doxorubicin Doses, Pharmaceutical Science, Liposome-encapsulated Doxorubicin +18

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

Priscilla K. Brastianos, Eudocia Q. Lee, Justine V. Cohen et al. · Nature Medicine · 2020 · 151 citations

Open-label Phase 2, Medicine, Leptomeningeal Carcinomatosis +7

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

Matthew J. Frigault, Jörg Dietrich, Kathleen Gallagher et al. · Blood · 2022 · 130 citations · Full text

Antitumor Activity of Liposome-Encapsulated Doxorubicin in Advanced Breast Cancer: Phase II Study

Joseph Treat, Andrew Greenspan, Deborah Forst et al. · JNCI Journal of the National Cancer Institute · 1990 · 123 citations